FDA issues bismacine-chromacine warning

Jul 24, 2006

The U.S. Food and Drug Administration is warning consumers and healthcare providers not to use a product called bismacine, also known as chromacine.

The FDA says it is investigating one report of a death and several reports of injury related to the administration of bismacine -- an injectable product that has been used to treat Lyme disease.

FDA officials said bismacine, which is not approved for anything, including Lyme disease, is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.

The product contains high amounts of bismuth, a heavy metal that is used in some medications to treat Helicobacter pylori, a bacteria that can cause stomach ulcers but that is not approved in any form for use by injection.

Copyright 2006 by United Press International

Explore further: Tips offered to docs, spouses for maintaining happy marriage

add to favorites email to friend print save as pdf

Related Stories

Throwing money at data breach may make it worse

18 minutes ago

Information systems researchers at the University of Arkansas, who studied the effect of two compensation strategies used by Target in reaction to a large-scale data breach that affected more than 70 million customers, have ...

How will Google, Apple shake up car insurance industry?

28 minutes ago

Car insurance industry, meet potential disrupters Google and Apple. Currently, nearly all mainstream insurers that offer driver-monitoring programs use relatively expensive devices that plug into a portal under the dashboard. ...

Researchers on expedition to solve 'small island problem'

28 minutes ago

Researchers from the Department of Electronic & Electrical Engineering are starting their new year with an expedition to the island of South Georgia to carry out research into improving weather forecasting. You can follow the team's progress on their blog. ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

28 minutes ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.

Child-safety expert offers tips for holiday gifts

58 minutes ago

Christmas is the most wonderful time of year, but it can quickly turn tragic if we're not careful, according to Bridget Boyd, MD, pediatric safety expert at Loyola University Health System.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.